← Every applicant
Sentiss FDA Approvals
4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| CIPROFLOXACIN AND DEXAMETHASONENew drugJun 9, 2023SUSPENSION/DROPS, OTIC |
| LOTEPREDNOL ETABONATENew drugApr 12, 2023SUSPENSION/DROPS, OPHTHALMIC |
| BRIMONIDINE TARTRATE AND TIMOLOL MALEATENew drugOct 31, 2022SOLUTION/DROPS, OPHTHALMIC |
| LOTEPREDNOL ETABONATENew drugFeb 10, 2021GEL, OPHTHALMIC |